Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Protein Kinase Inhibitors"
topic_facet:"53AH36668S"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Protein+Kinase+Inhibitors%22&filter%5B%5D=topic_facet%3A%2253AH36668S%22&lookfor=%22Shi%2C+Yuankai%22&type=Person
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Protein+Kinase+Inhibitors%22&filter%5B%5D=topic_facet%3A%2253AH36668S%22&lookfor=%22Shi%2C+Yuankai%22&type=Person
Search /vufind/Search2/Results?filter%5B%5D=topic_facet%3A%22Protein+Kinase+Inhibitors%22&filter%5B%5D=topic_facet%3A%2253AH36668S%22&lookfor=%22Shi%2C+Yuankai%22&type=Person
PubPharm (8)
1
Efficacy and safety of iruplinalkib (WX-0593) in ALK-positive crizotinib-resistant advanced non-small cell lung cancer patients : a single-arm, multicenter phase II study (INTELLECT)
enthalten in:
BMC medicine
| 2023
von
Shi, Y.
|
Chen, J.
|
Zhang, H.
| +30
Wird geladen...
2
Conteltinib (CT-707) in patients with advanced ALK-positive non-small cell lung cancer : a multicenter, open-label, first-in-human phase 1 study
enthalten in:
BMC medicine
| 2022
von
Xing, P.
|
Zhao, Q.
|
Zhang, L.
| +5
Wird geladen...
3
Toxicity profile of anaplastic lymphoma kinase tyrosine kinase inhibitors for patients with non-small cell lung cancer : A systematic review and meta-analysis
enthalten in:
Investigational new drugs
| 2022
von
Tao, Y.
|
Zhou, Y.
|
Tang, L.
| +3
Wird geladen...
4
Role of chemokine-mediated angiogenesis in resistance towards crizotinib and its reversal by anlotinib in EML4-ALK positive NSCLC
enthalten in:
Journal of translational medicine
| 2022
von
Wang, S.
|
Lou, N.
|
Luo, R.
| +5
Wird geladen...
5
Phase 1/2 study of ceritinib in Chinese patients with advanced anaplastic lymphoma kinase-rearranged non-small cell lung cancer previously treated with crizotinib : Results from ASCEND-6
enthalten in:
Lung cancer (Amsterdam, Netherlands)
| 2020
von
Wu, Y.
|
Shi, Y.
|
Tan, D.
| +11
Wird geladen...
6
CT-707 Overcomes Resistance of Crizotinib through Activating PDPK1- AKT1 Pathway by Targeting FAK
enthalten in:
Current cancer drug targets
| 2019
von
Liang, C.
|
Zhang, N.
|
Tan, Q.
| +5
Wird geladen...
7
A standardized protocol for detection of ALK protein expression and gene fusion in lung adenocarcinoma cytologic specimens
enthalten in:
Zhonghua zhong liu za zhi [Chinese journal of oncology
| 2015
von
Wang, Z.
|
Wu, X.
|
Shi, Y.
| +13
Wird geladen...
8
The molecular detection and clinical significance of ALK rearrangement in selected advanced non-small cell lung cancer : ALK expression provides insights into ALK targeted therapy
enthalten in:
PloS one
| 2014
von
Zhang, N.
|
Liu, Y.
|
Ma, L.
| +10
Wird geladen...
1
[1]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Thema: Protein Kinase Inhibitors
Filter aufheben
Thema: 53AH36668S
Medienart
8
Aufsätze
7
E-Artikel
7
E-Ressourcen
1
Gedruckte Aufsätze
Zeitschriftentitel
2
BMC medicine
1
Current cancer drug targets
1
Investigational new drugs
1
Journal of translational medicine
1
Lung cancer (Amsterdam, Netherlands)
1
PloS one
1
Zhonghua zhong liu za zhi [Chinese journal of o...
Alle anzeigen ...
weniger ...
Thema
53AH36668S
8
Crizotinib
8
Journal Article
Protein Kinase Inhibitors
7
Research Support, Non-U.S. Gov't
5
Anaplastic Lymphoma Kinase
5
EC 2.7.10.1
3
Anaplastic lymphoma kinase
3
Non-small cell lung cancer
3
Protein-Tyrosine Kinases
3
Pyrazoles
2
Antineoplastic Agents
2
CT-707
2
Clinical Trial, Phase I
2
Clinical Trial, Phase II
2
Multicenter Study
2
Pyridines
2
Receptor Protein-Tyrosine Kinases
2
Tyrosine kinase inhibitor
1
3-Phosphoinositide-Dependent Protein Kinases
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
5
2020-
3
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
7
Englisch
1
Chinesisch
Haven't found what you're looking for?
Wird geladen...